IL37 and autoimmune disease: However, dysregulated/upregulated IL-37 expression is observed in autoimmune diseases, including rheumatoid arthritis (37), psoriasis, Grave’s disease, gestational diabetes mellitus (39), systemic lupus erythematosus and inflammatory bowel disease (38).